Moxifloxacina Ciclum

Moxifloxacin, the active ingredient in Moxifloxacina Ciclum, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats a range of serious bacterial infections in adult patients, including pneumonia, sinusitis, bronchitis exacerbations, skin infections and intra‑abdominal infections.

GNH USA supplies Moxifloxacina Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in various organ systems. - Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation by eliminating the infecting bacteria. - Acute bacterial exacerbations of chronic bronchitis: controls bacterial load and alleviates worsening cough and sputum production. - Skin and soft tissue infections: achieves bacterial clearance in cellulitis, abscesses and wound infections. - Complicated intra‑abdominal infections: provides effective coverage against mixed aerobic and anaerobic organisms.

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional vertiginous sensations. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient hepatic enzyme changes.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, requiring immediate medical attention. - QT interval prolongation: may precipitate cardiac arrhythmias. - Severe hypersensitivity: including Stevens‑Johnson syndrome. - Clostridioides difficile colitis: severe diarrhea with pseudomembranous colitis. - Peripheral neuropathy: persistent numbness or tingling. - Hepatotoxicity: significant liver injury with jaundice.

Moxifloxacin should be used with caution and under professional supervision. - Renal impairment: adjust therapy based on renal function. - Hepatic disease: monitor liver function tests during treatment. - Cardiac risk: avoid in patients with known QT prolongation or electrolyte disturbances. - Tendon disorders: discontinue if tendon pain or swelling occurs. - Pregnancy and lactation: use only if the potential benefit outweighs the risk. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Moxifloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of moxifloxacin. - NSAIDs (e.g., ibuprofen, diclofenac): increase risk of central nervous system stimulation. - QT‑prolonging agents (e.g., quinidine, macrolides): may cause serious cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Corticosteroids: increase risk of tendon rupture. - Theophylline: may raise serum theophylline levels, necessitating dosage adjustment.